- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06478303
Circuits d'imagerie langage-moteur pour améliorer l'apprentissage moteur et la compréhension du langage (LAMI)
Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. For instance, motor training (e.g., sports, origami training) can facilitate action verb recognition, whereas motor deficits (e.g., upper limb immobilization) can hinder the processing of action language. Similarly, action language has been shown to affect motor performance. These effects are attributed to an implicit form of motor imagery, an automatic simulation of motor experience (without actual movement) evoked by action words. Interestingly, literature supports the idea that the motor simulations used for imagining an action are also engaged during the reading of action language, leading to similar neurophysiological and behavioral changes in both processes. However, questions remain about the similarity of the simulations generated by motor imagery and action language. This project, encompassing three experimental sequences, aims to address these questions to achieve significant scientific advancements in both theoretical and applied domains.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Laurent VERCUEIL
- Numéro de téléphone: 0476765561
- E-mail: LVercueil@chu-grenoble.fr
Sauvegarde des contacts de l'étude
- Nom: William DUPONT
- Numéro de téléphone: +33 (0)6 67 76 00 99
- E-mail: william.dupont@univ-grenoble-alpes.fr
Lieux d'étude
-
-
-
Dijon, France
- Recrutement
- Université de Bourgogne
-
Contact:
- William DUPONT
- Numéro de téléphone: +33 (0)6 67 76 00 99
- E-mail: william.dupont@univ-grenoble-alpes.fr
-
Contact:
- Florent LEBON
- Numéro de téléphone: +33 (0)3 80 39 67 54
- E-mail: Florent.Lebon@u-bourgogne.fr
-
Chercheur principal:
- Florent LEBON
-
-
Grenob
-
Grenoble, Grenob, France, 38043
- Recrutement
- CHU Grenoble Alpes
-
Chercheur principal:
- Laurent VERCUEIL
-
Contact:
- William DUPONT
- Numéro de téléphone: +33 (0)6 67 76 00 99
- E-mail: william.dupont@univ-grenoble-alpes.fr
-
Contact:
- Laurent VERCUEIL
- Numéro de téléphone: +33 (0)4 76 76 55 61
- E-mail: LVercueil@chu-grenoble.fr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Subjects will be aged between 18 and 40, reading and understanding French, with no neurological or psychiatric disorders, no uncorrected vision deficits, and meeting all MRI or TMS examination criteria. they were recruited at the University of Burgundy (TMS measures only) and the University of Grenoble Alpes (fMRI measures only).
La description
Inclusion Criteria:
- persons who have given written consent,
- healthy subjects
- subjects reading and understanding French
- right-handed,
- affiliated with a social security system,
- between 18 and 40 years old,
- had completed the TMS inclusion questionnaire or had undergone a medical examination prior to participation in the MRI study.
Exclusion Criteria:
- Existence of a severe general medical condition: cardiac, respiratory, hematological, renal, hepatic, cancerous,
- Regular use of anxiolytics, sedatives, antidepressants, neuroleptics,
- Characterized psychiatric pathology,
- Ingestion of alcohol prior to the examination,
- Persons covered by articles L1121-5 to L1121-8 of the CSP,
- Presence of contraindications to MRI or TMS.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_CONTROL
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
groupe de contrôle
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Groupe expérimental TMS
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Groupe expérimental IRMf
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements Participants were asked to perform arm or foot movements |
|
Groupe expérimental ccPAS
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
|
Groupe ccPAS fictif
|
Participants were asked to imagine arm or foot movements. Participants were asked to read sentences involving arm or foot movements |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Level of corticospinal excitability
Délai: 1 hour and 30 minutes
|
this is a physiological response obtained by transcranial magnetic pulses (TMS). This is an indicator of the excitability of the motor system, which can be used at rest or during various cognitive tasks (motor imagery or action reading). |
1 hour and 30 minutes
|
|
Cortical activation (BOLD signal)
Délai: 1 hour
|
this is a cortical response obtained via a fMRI. This is an indicator of the brain activity, which can be used at rest or during motor and cognitive tasks (motor imagery or action reading). |
1 hour
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Laurent VERCUEIL, CHU Grenoble Alpes
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 38RC23.0349
- 2023-A02322-43 (Autre identifiant: ID RCB)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .